GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Net Change in Cash

American Vietnamese Biotech (HSTC:AMV) Net Change in Cash : ₫0.00 Mil (TTM As of . 20)


View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

American Vietnamese Biotech's Net Change in Cash for the three months ended in . 20 was ₫0.00 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in . 20 was ₫0.00 Mil.

American Vietnamese Biotech Net Change in Cash Historical Data

The historical data trend for American Vietnamese Biotech's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Net Change in Cash Chart

American Vietnamese Biotech Annual Data
Trend
Net Change in Cash

American Vietnamese Biotech Quarterly Data
Net Change in Cash

American Vietnamese Biotech Net Change in Cash Calculation

American Vietnamese Biotech's Net Change in Cash for the fiscal year that ended in . 20 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=+++
=0.00

American Vietnamese Biotech's Net Change in Cash for the quarter that ended in . 20

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=+++
=0.00

Net Change in Cash for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was ₫0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Vietnamese Biotech Net Change in Cash Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

American Vietnamese Biotech (HSTC:AMV) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Net Change in Cash
Comparable Companies
BOM:524796 BOM:532041 BOM:506365 HSTC XSAT:EURI B STLT CTBO MBVXQ WAR:PFM NTRR GWSN BOM:524604 GTHR IMUC ARGSQ SOAN TSXV:PBS ATMS LSE:ANIC TSXV:COT
Traded in Other Exchanges
N/A
Address
20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM
Website
http://www.amvibiotech.com
American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.

American Vietnamese Biotech (HSTC:AMV) Headlines

From GuruFocus

Atlis Motor Vehicles on Pace to Achieve Exponential Growth in 2023, Sets Goal to Double 2022 Headcount in Response to Growing Demand

By Stock market mentor Stock market mentor • 02-07-2023

Atlis Motor Vehicles to Participate in the Electric Vehicle & Auto Tech Virtual Conference Presented by Maxim Group and Hosted by M-Vest on Thursday, March 30th at 12:00 P.M. ET

By sperokesalga sperokesalga • 03-28-2023

Atlis Motor Vehicles to Host Special Shareholder Meeting; Seeks Approval of Holding Company Restructuring and Omnibus Incentive Plan

By sperokesalga sperokesalga • 05-04-2023

Atlis Motor Vehicles Secures Two Key Test Pack Purchase Orders from EV Manufacturers

By Value_Insider Value_Insider • 11-14-2022

Atlis Motor Vehicles Expands Executive Team, Welcomes Srinivas Jasthi as Vice President of Software

By sperokesalga sperokesalga • 03-30-2023

Atlis Motor Vehicles Enters Mass Production Trial of AMV Battery Technology

By Value_Insider Value_Insider • 11-15-2022

Atlis Motor Vehicles to Host Investor Town Hall on Monday, March 20, 2023, at 7:30pm ET / 4:30pm PT

By sperokesalga sperokesalga • 03-20-2023

Atlis Motor Vehicles to Hold Live Stream Town Hall on November 15, 2022 at 12:00pm ET / 9:00am PT

By Value_Insider Value_Insider • 11-12-2022

Atlis Motor Vehicles Debuts Proprietary Megawatt AC/DC Charge Handle and Cable Design, Successfully Delivering Unprecedented 1,200A+ and 1,000V+ in Charge Tests

By Stock market mentor Stock market mentor • 01-31-2023

Atlis Motor Vehicles, Inc. Announces Pricing of $13.0 Million Public Offering

By sperokesalga sperokesalga • 02-16-2023